Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the …

WJ Heinz, D Buchheidt, M Christopeit… - Annals of …, 2017 - Springer
Fever may be the only clinical symptom at the onset of infection in neutropenic cancer
patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based …

Bloodstream infections in neutropenic cancer patients: a practical update

G Gustinetti, M Mikulska - Virulence, 2016 - Taylor & Francis
abstract Bloodstream infections (BSI) are among the most frequent complications in
neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high …

Management of febrile neutropaenia: ESMO clinical practice guidelines

J Klastersky, J De Naurois, K Rolston… - Annals of …, 2016 - annalsofoncology.org
Despite major advances in prevention and treatment, FN remains one of the most frequent
and serious complications of cancer chemotherapy (ChT). It is a major cause of morbidity …

Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America …

RA Taplitz, EB Kennedy, EJ Bow, J Crews… - Journal of Clinical …, 2018 - ascopubs.org
Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …

Human health risk assessment of antibiotics in binary mixtures for finished drinking water

M Kumari, A Kumar - Chemosphere, 2020 - Elsevier
The present study developed a new step-wise approach to estimate the potential human
health risk of antibiotics in binary mixture for drinking water samples for two different sub …

[HTML][HTML] Bacterial infections in hematopoietic stem cell transplant recipients

E Balletto, M Mikulska - Mediterranean journal of hematology and …, 2015 - ncbi.nlm.nih.gov
Bacterial infections are major complications after Hematopoietic Stem Cell Transplant
(HSCT). They consist mainly of bloodstream infections (BSI), followed by pneumonia and …

Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update

P Villafuerte-Gutierrez, L Villalon, JE Losa… - Advances in …, 2014 - Wiley Online Library
Febrile neutropenia is one of the most serious complications in patients with haematological
malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic …

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

B Pothuri, AA Secord, DK Armstrong, J Chan… - Gynecologic …, 2020 - Elsevier
Objectives The COVID-19 pandemic has consumed considerable resources and has
impacted the delivery of cancer care. Patients with cancer may have factors which place …

Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia

C Fontanella, S Bolzonello, B Lederer, G Aprile - Breast care, 2014 - karger.com
Chemotherapy-induced neutropenia (CIN) is a common toxicity caused by the
administration of anticancer drugs. This side effect is associated with life-threatening …

Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers …

S Ahn, TW Rice, SJ Yeung, T Cooksley - Supportive Care in Cancer, 2018 - Springer
Purpose Patients with febrile neutropenia are a heterogeneous group with a minority
developing serious medical complications. Outpatient management of low-risk febrile …